Trials / Unknown
UnknownNCT01581502
SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF)
Stroke Acute Management With Urgent Risk-factor Assessment and Improvement (SAMURAI) Study on Anticoagulant Therapy in Nonvalvular Atrial Fibrillation (NVAF)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Ministry of Health, Labour and Welfare, Japan · Other Government
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine choice of anticoagulant therapy during acute and chronic stages of ischemic stroke/TIA and short- and long-term outcomes, including stroke recurrence and bleeding complications, in patients having nonvalvular atrial fibrillation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | This is an observational study. | This is an observational, not intervention, study. |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2016-03-01
- Completion
- 2016-12-01
- First posted
- 2012-04-20
- Last updated
- 2015-09-02
Locations
16 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01581502. Inclusion in this directory is not an endorsement.